Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities.
The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched by the Ministry of Social Justice and Empowerment (MoSJE) (selection partners for Startups) and managed by IFCI Venture, a subsidiary of IFCI Limited and Small Industries Development Bank of India (SIDBI). The investment reflects growing institutional interest in preventive health platforms that are building for scale and real-world impact.
With this capital, the company plans to further strengthen its technology stack, expand clinical capabilities and enhance its product offerings, particularly in building scalable, evidence-based solutions that integrate seamlessly across both consumer and clinical workflows.
Rahul Krishnan, Co-founder & CPO, Ivory, said, “Our focus at Ivory is to make brain health measurable and actionable, much like other key health biomarkers. This round allows us to deepen our clinical and product capabilities, while continuing to build a scalable, digital-first layer for cognitive screening across both consumers and healthcare systems.”
Anish Babu, Managing Director, IFCI Venture, said, “Ivory is addressing a significant unmet need in cognitive health through a clinically grounded and technology-led approach. We are pleased to support their journey as they work towards making early cognitive screening more accessible and mainstream in India.”
The company has also been expanding its partnerships across the healthcare ecosystem. Most recently, Ivory collaborated with Metropolis Healthcare, a multinational chain of diagnostic labs, to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments.
This offering brings together physical and cognitive health into a single screening experience, enabling individuals to track key cognitive functions such as memory, attention, and executive function alongside traditional health markers, reflecting a more holistic approach to preventive care.
